|Year : 2021 | Volume
| Issue : 1 | Page : 56-59
Sub-internal limiting membrane hemorrhage as an unusual presentation of polypoidal choroidal vasculopathy
George Joseph Manayath, Shishir Verghese, Ratnesh Ranjan, Venkatapathy Narendran
Department of Retina and Vitreous, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India
|Date of Submission||24-Aug-2020|
|Date of Decision||12-Dec-2020|
|Date of Acceptance||09-Feb-2021|
|Date of Web Publication||27-Feb-2021|
Dr. Shishir Verghese
Department of Retina and Vitreous, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Civil Aerodrome Post, Peelamedu, Coimbatore - 641 014, Tamil Nadu
Source of Support: None, Conflict of Interest: None
| Abstract|| |
We report the two cases who presented with sudden decreased vision and sub-internal limiting membrane (ILM) hemorrhage without a history of Valsalva maneuver, trauma, or hematological disorders. Multimodal imaging revealed the features suggestive of polypoidal choroidal vasculopathy (PCV) in addition to the sub-ILM hemorrhage. A provisional diagnosis of sub-ILM hemorrhage secondary to PCV was made and was treated with intravitreal Bevacizumab injection. Treatment resulted in the improved visual acuity along with the resolution of the sub-ILM hemorrhage. These cases highlight the possibility of isolated sub-ILM hemorrhage as a presenting fundus finding in PCV, which is previously unreported. This report also highlights the importance of multimodal imaging in diagnosing chorioretinal disorders with unusual presentation.
Keywords: Polypoidal choroidal vasculopathy, subinternal limiting membrane hemorrhage, Valsalva retinopathy
|How to cite this article:|
Manayath GJ, Verghese S, Ranjan R, Narendran V. Sub-internal limiting membrane hemorrhage as an unusual presentation of polypoidal choroidal vasculopathy. Oman J Ophthalmol 2021;14:56-9
|How to cite this URL:|
Manayath GJ, Verghese S, Ranjan R, Narendran V. Sub-internal limiting membrane hemorrhage as an unusual presentation of polypoidal choroidal vasculopathy. Oman J Ophthalmol [serial online] 2021 [cited 2022 Nov 29];14:56-9. Available from: https://www.ojoonline.org/text.asp?2021/14/1/56/190155
| Introduction|| |
Polypoidal choroidal vasculopathy (PCV) is characterized by the presence of choroidal polypoidal lesions, which could manifest as hemorrhagic or exudative type. Hemorrhagic PCV usually presents with sudden painless loss of vision due to subretinal fluid (SRF) associated with subretinal hemorrhage, subretinal pigment epithelial (RPE) hemorrhage, and occasionally break-through vitreous hemorrhage (VH). Isolated sub-internal limiting membrane (ILM) hemorrhage is not a reported clinical presentation of PCV till date. The common causes of sub-ILM hemorrhages include Valsalva retinopathy, Terson syndrome, retinal artery macroaneurysm (RAM), hematological disorders, trauma, or idiopathic. However, PCV has not been reported as a cause of isolated sub-ILM hemorrhage.
We describe the two cases of PCV presenting with sub-ILM hemorrhage.
| Case Report|| |
A 46-year-old male was referred to us with sudden painless decreased vision in the right eye (RE) for 1 month. His medical record and optical coherence tomography (OCT) image (taken immediately after onset of complaints by the referring ophthalmologist) showed the presence of sub-ILM hemorrhage with SRF and pigment epithelial detachments (PEDs) [Figure 1]d. He had no history of systemic illnesses, Valsalva maneuver, or trauma. His best-corrected visual acuity (BCVA) in the RE was 20/200. RE fundus examination and OCT revealed the presence of foveal sub-ILM hemorrhage, SRF, small irregular notched PEDs, and double-layer sign [Figure 1]a and [Figure 1]e. All blood investigations, including complete blood count and coagulation profile, were within the normal range. A diagnosis of RE PCV was made based on fundus fluorescein angiography (FFA) and Indocyanine green angiography (ICG) features [Figure 1]b, [Figure 1]c, [Figure 1]d. The patient was treated with RE intravitreal Bevacizumab (IVB) injection. One month later, fundus examination and OCT showed a reduction in the sub-ILM hemorrhage, disappearance of SRF, and reduction in the size of PEDs [Figure 2]a and [Figure 2]d with BCVA improving to 20/60. IVB injection was repeated in the RE. At 1 month following second injection, RE BCVA improved to 20/30 with fundus appearing grossly normal and OCT showing near complete resolution of sub-ILM hemorrhage and flattening of PEDs [Figure 2]b. An enhanced-depth imaging (EDI) O OCT done at this stage showed a choroidal thickness of 400μ in the RE suggestive of pachychoroid [Figure 2]c.
|Figure 1: Baseline color fundus photo of the right eye showing drop-shaped sub-internal limiting membrane hemorrhage at the fovea (a); fundus fluorescein angiography showing blocked fluorescence confirming the subinternal limiting membrane hemorrhage with otherwise normal findings (b); Indocyanine green showing a hyper-fluorescent nodule at the edge of the blocked fluorescence due to subinternal limiting membrane hemorrhage (c); optical coherence tomography image (taken immediately after the onset of complaints by referring doctor) showing sub-internal limiting membrane hemorrhage with after shadowing and PEDs (d); optical coherence tomography through the fovea showing reducing sub-internal limiting membrane hemorrhage with after-shadowing along with increased sub-retinal fluid and small irregular notched PED (e)|
Click here to view
|Figure 2: Optical coherence tomography macula 1 month after the 1st injection showing minimal residual sub-internal limiting membrane hemorrhage with resolution of sub-retinal fluid and reduction in size of PED (a); optical coherence tomography image at 1 month after second injection showing the complete resolution of sub-internal limiting membrane hemorrhage and flattening of PED (b); Enhanced depth imaging optical coherence tomography showing thickened choroid with dilated outer choroidal vessels suggestive of pachychoroid (c); Color fundus photo at the final visit showing complete resolution of sub- internal limiting membrane hemorrhage (d)|
Click here to view
A 58-year-old female presented with sudden painless decreased vision in the left eye (LE) for 1 month. There was no history of any Valsalva maneuver or trauma. BCVA in the RE was 20/20 and LE was 20/200. Fundus examination as well as OCT LE showed hemorrhagic PED at the fovea and sub-ILM hemorrhage at inferonasal macula [Figure 3]a and [Figure 3]d. LE EDI-OCT confirmed the presence of pachychoroid in the BE [Figure 3]d. ICG did not reveal any hyperfluorescence in the LE due to masking by the hemorrhagic PED [Figure 3]b and [Figure 3]c. Hematological investigations were normal. With a provisional diagnosis of PCV, she was treated with LE IVB injection. At 1-month follow-up, her LE vision improved to 20/125. Fundus examination revealed the disappearance of sub-ILM hemorrhage with a reduction in the size of hemorrhagic PED which were confirmed on OCT [Figure 3]e, [Figure 3]f, [Figure 3]g.
|Figure 3: Color fundus photo of the left eye showing the hemorrhagic PED (black arrow) and sub-internal limiting membrane hemorrhage (white arrow) (a); Early and late phases of Indocyanine green angiogram showing blocked fluorescence due to the haemorrhagic PED (b and c); optical coherence tomography images at presentation showing hemorrhagic PED with after shadowing, thick choroid with dilated outer choroidal vessels and sub-internal limiting membrane hemorrhage (d and e); optical coherence tomography images at 1 month postinjection shows the reduction in size of hemorrhagic PED and disappearance of sub-internal limiting membrane hemorrhage (f and g)|
Click here to view
| Discussion|| |
Both cases highlight the fact that PCV may also present with isolated sub-ILM hemorrhage like Valsalva retinopathy. Multimodal imaging has an important diagnostic role in the absence of other common causes of sub-ILM hemorrhage such as Valsalva retinopathy, Terson syndrome, and RAM.
Valsalva retinopathy presents with sudden visual loss in a healthy individual caused by sub-hyaloid or/and sub-ILM hemorrhage secondary to Valsalva stress such as vomiting, coughing, and physical stress. Valsalva maneuver causes increased intrathoracic pressure leading to an increased pressure in the intraocular veins, resulting in the spontaneous rupture of the perifoveal capillaries. Despite the presence of sub-ILM hemorrhage, Valsalva retinopathy was ruled out in both cases due to the absence of any significant history such as forceful expiration, vomiting, straining or weight-lifting, and presence of alternate findings on multimodal imaging.
Terson syndrome presents with VH, sub-hyaloid, or sub-ILM hemorrhage in the presence of intracranial hemorrhage. The postulated pathogenesis involves the rupture of the thin retinal capillary walls secondary to increased intracranial pressure transmitted through the optic nerve sheath and veins causing hydro-dissection of the ILM from the neurosensory retina. This entity was also ruled out due to the absence of a history of head injury or features of raised intracranial pressure.
RAM is an acquired abnormality of retinal vasculature, characterized by outpouching of major retinal arteriole usually seen in hypertensive females. Hemorrhagic RAM can cause multilevel hemorrhage including sub-ILM, usually associated with macular edema. A saccular or fusiform hyperfluorescence is seen on FFA with rapid early filling in saccular RAM and minimal in fusiform RAM. RAM was excluded in our cases due to the absence of characteristic fundus picture and noncorroborative FFA findings.
Blood dyscrasias such as anemia, thrombocytopenia, and pancytopenia are known to cause multilevel hemorrhages including sub-ILM hemorrhage due to reduced endothelial cell integrity and coagulability. Fundus examination shows the presence of Roth's spots and flame-shaped hemorrhage. Hematological workup for both patients was normal, and hence, these causes were ruled out.
In the setting of PED with SRF or hemorrhage in a middle aged or older patient, the possible causative sub-RPE lesions include wet age-related macular degeneration (ARMD) type 1 choroidal neo-vascular membrane (CNVM) or type 3 retinal angiomatous proliferation or PCV. Type 1 Vascularized PED in ARMD presents with subretinal hemorrhage and Type 3 with usually intra-retinal hemorrhage, with typical ARMD features like drusen in older patients. In the Indian or Asian scenario, 20%–60% patients presenting as neovascular ARMD are seen to be PCV, especially younger patients without typical ARMD features like drusen. Sub-ILM hemorrhage (without subretinal or intraretinal haemorrhage) as the presenting fundus finding has not been reported in PCV or Type 1 CNVM. Various findings noted on multimodal imaging in both cases lead us to consider PCV as the underlying pathology. The findings suggestive of PCV included OCT showing SRF with PED in case 1, a hemorrhagic PED in case 2 and pachychoroid features in both cases, and angiographic features in case 1. ICGA did not reveal a polyp, especially in case 2, but in the majority of hemorrhagic PCV cases, the sub-retinal or sub-RPE blood blocks/masks the classic finding of branched vascular network or polyps. Further, the resolution of SRF and flattening of PEDs in response to anti-VEGF injections supported the diagnosis.
To the best of our knowledge, sub-ILM hemorrhage as the presenting fundus finding in PCV has not been reported previously in the literature. Hemorrhagic PCV usually presents with sub-retinal and sub-RPE hemorrhage. Occasionally, massive hemorrhages may develop from the rupture of venules or sometimes arteries, resulting in break-through vitreous hemorrhage. However, an aborted hemorrhage which failed to rupture ILM could be the probable pathogenesis of sub-ILM hemorrhage in our cases.
| Conclusion|| |
This report highlights a new clinical presentation pattern of PCV with isolated sub-ILM hemorrhage, which is previously unreported, and also underlines the importance of multimodal imaging for the diagnosis of chorioretinal disorders with unusual presentations.
Declaration of patient consent
The authors certify that they had obtained all appropriate patient consent forms. In the form, the patients have given their consent for their images, and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, et al.
Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management. Ophthalmology 2018;125:708-24.
De Maeyer K, Van Ginderdeuren R, Postelmans L, Stalmans P, Van Calster J. Sub-inner limiting membrane haemorrhage: Causes and treatment with vitrectomy. Br J Ophthalmol 2007;91:869-72.
Georgiou T, Pearce IA, Taylor RH. Valsalva retinopathy associated with blowing balloons. Eye (Lond) 1999;13 ( Pt 5):686-7.
Ko F, Knox DL. The ocular pathology of Terson's syndrome. Ophthalmology 2010;117:1423-900.
Moosavi RA, Fong KC, Chopdar A. Retinal artery macroaneurysms: Clinical and fluorescein angiographic features in 34 patients. Eye (Lond) 2006;20:1011-20.
Pitkänen L, Tommila P, Kaarniranta K, Jääskeläinen JE, Kinnunen K. Retinal arterial macroaneurysms. Acta Ophthalmol 2014;92:101-4.
Mansour AM, Salti HI, Han DP, Khoury A, Friedman SM, Salem Z, et al.
Ocular findings in aplastic anemia. Ophthalmologica 2000;214:399-402.
[Figure 1], [Figure 2], [Figure 3]